Related Experiment Video
Updated: Apr 28, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
Published on: September 30, 2025
Dissociation Between Cholesteryl Ester Transfer Protein Mass and Activity in Coronary Artery Disease Patients with
Tolga Kunak1, Ayşegül Ülgen Kunak2, Adnan Abacı3
1Department of Cardiology, Akdeniz University, Faculty of Medicine, Antalya, Türkiye.
Insights
Increased cholesteryl ester transfer protein (CETP) activity, not mass, is linked to coronary artery disease (CAD) in patients with high HDL-C and LDL-C. This suggests CETP function contributes to residual cardiovascular risk.
Area of Science:
- Cardiovascular Disease Research
- Lipid Metabolism Studies
- Atherosclerosis Pathophysiology
Background:
- High-density lipoprotein cholesterol (HDL-C) is traditionally considered cardioprotective.
- Elevated HDL-C in some coronary artery disease (CAD) patients challenges this notion.
- Investigating HDL subclasses, apolipoproteins, and CETP in CAD with high HDL-C and LDL-C is crucial.
Purpose of the Study:
- To explore the roles of HDL subclasses, apolipoproteins, and CETP activity/mass in CAD patients with high HDL-C and LDL-C.
- To determine if CETP activity or mass is associated with CAD in this specific patient group.
- To assess the relationship between CETP activity and CAD using correlation and regression analyses.
Main Methods:
- Enrolled 35 CAD patients and 35 matched controls with high HDL-C (≥ 60 mg/dL) and LDL-C (≥ 130 mg/dL).
- Measured CETP mass and activity, apolipoprotein A-I (ApoA-I), ApoA-II, ApoB, and HDL subclasses (HDL2, HDL3).
- Utilized correlation analyses and multivariate logistic regression to evaluate CETP activity's association with CAD.
Main Results:
- CETP activity was significantly higher in CAD patients versus controls (P = .007).
- CETP mass, HDL2, and HDL3 levels did not differ between groups.
- ApoA-I levels were paradoxically higher in CAD patients (P = .006); CETP activity independently predicted CAD (OR 2.03, P = .002).
Conclusions:
- Increased CETP activity, not mass, is associated with CAD in patients with high HDL-C and LDL-C.
- This suggests CETP function may contribute to residual cardiovascular risk.
- Elevated ApoA-I and HDL dysfunction, not just quantity, are key in atheroprotection, supporting functional lipoprotein evaluation.
Background:
High-density lipoprotein cholesterol (HDL-C) is traditionally viewed as cardioprotective; however, some patients with coronary artery disease (CAD) may present with elevated HDL-C levels, challenging this assumption. This study aimed to investigate the roles of HDL subclasses, apolipoproteins, and cholesteryl ester transfer protein (CETP) activity and mass in patients with CAD with high HDL-C and low-density lipoprotein cholesterol (LDL-C) levels.
Methods:
A total of 35 patients with CAD and 35 age- and lipid-matched control participants (HDL-C ≥ 60 mg/dL and LDL-C ≥ 130 mg/dL) were enrolled. Cholesteryl ester transfer protein mass and activity, apolipoprotein A-I (ApoA-I), ApoA-II, ApoB, and HDL subclasses (HDL2 and HDL3) were measured and compared between groups. Correlation analyses and multivariate logistic regression were performed to assess the relationship between CETP activity and CAD.
Results:
The CETP activity was significantly higher in patients with CAD compared with control participants (1.08 vs. 0.98 nmol/μL/h, P = .007), whereas CETP mass, HDL2, and HDL3 levels were similar. The ApoA-I levels were paradoxically higher in patients with CAD (P = .006), with no differences in ApoA-II or ApoB. In multivariate analysis, CETP activity remained independently associated with CAD after adjusting for age and sex (OR 2.03; 95% CI 1.27-3.24; P = .002).
Conclusion:
In patients with high HDL-C and LDL-C, increased CETP activity-but not mass-was associated with the presence of CAD, suggesting CETP function may con-tribute to residual cardiovascular risk. Elevated ApoA-I levels in patients with CAD may reflect dysfunctional HDL, emphasizing that HDL quality, rather than quantity, plays a more critical role in atheroprotection. These findings support a functional evaluation of lipoproteins in cardiovascular risk assessment.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Coronary Artery Disease II: Pathophysiology
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

